Harvey AI vs Iris.ai (2026)

Harvey AI

by Harvey

Iris.ai

by Iris.ai

Pros

• ✓Harvey Agents execute complex legal work end-to-end: from contract analysis and due diligence through document drafting and research, agents create plans, execute across connected systems, and deliver results without step-by-step attorney direction. This represents the highest autonomous capability of any legal AI platform in the index.
• ✓$1.22B raised from Sequoia, Andreessen Horowitz, Kleiner Perkins, GIC, and OpenAI at $11B valuation with $190M ARR. This is the strongest funding, revenue, and institutional backing of any legal AI company, with named enterprise clients including Dentons, KKR, Bridgewater, PwC, Deutsche Telekom, and Procter and Gamble alongside the majority of top global law firms.
• ✓Action-level DMS integration creates, reads, and updates documents in iManage, NetDocuments, and SharePoint with research grounded in Westlaw and LexisNexis. Harvey participates in the full document lifecycle of legal matters rather than operating as a standalone research tool.

Limitations

• ⚠Enterprise-only pricing with no self-serve option: typical annual contracts run six figures, making Harvey inaccessible for solo practitioners and small firms. Spellbook (custom pricing, demo-gated) and Consensus ($12/mo billed annually) provide accessible entry points for basic legal AI capabilities.
• ⚠Deployment requires 4 to 12 weeks including firm security review, custom model configuration, DMS integration, and attorney training. This is not a tool teams can activate and evaluate quickly, creating friction for firms weighing AI adoption against faster-deploying alternatives.
• ⚠Review volume significantly understates actual adoption: 2 G2 reviews and 6 Gartner ratings as of July 2026 despite 142,000+ active professionals. Procurement teams relying on review platforms for vendor evaluation will find thin public evidence relative to deployment scale.

Pros

• ✓Named enterprise adoption across Fortune 500 and government organizations: Mercedes-Benz, ArcelorMittal, USDA, Max Planck Gesellschaft, Springer Nature, and the NATO Communications and Information Agency appear on the official vendor homepage, providing procurement validation that is rare in the regulated enterprise AI infrastructure category.
• ✓Three-product architecture covers the full data-to-AI lifecycle: Axion handles data preparation into AI-ready intelligence, Neuralith powers the enterprise knowledge graph engine, and RSpace delivers precision R&D intelligence. That end-to-end coverage is something fragmented stacks, which require separate vendors for data preparation and AI agent deployment, cannot match.
• ✓A ten-year track record from 2015 through multiple product pivots demonstrates operational maturity. The evolution from academic research AI through scientific language models to Agentic RAG-as-a-Service shows sustained development velocity and enterprise customer retention that AI challengers founded after 2020 cannot replicate.

Limitations

• ⚠No public independent review trail creates procurement friction: the G2 listing was removed in 2026, Trustpilot returns 404, and no Capterra presence exists, so third-party validation outside the vendor homepage logos is difficult. Tools such as Elicit ($49/mo billed annually) and SciSpace ($12/mo billed annually) offer G2-verified reviews for procurement teams that require independent evidence.
• ⚠Named integration depth is not published: the Agentic RAG positioning implies broad enterprise data connectivity, but specific native integrations with SAP, Salesforce, Veeva Vault, SharePoint, PubMed, or Scopus are not confirmed, requiring sales-led scoping before integration depth can be evaluated.
• ⚠Enterprise-only entry with no self-serve evaluation path excludes individual researchers, academic teams, and smaller organizations: the platform requires sales-led engagement, custom data engineering, and sustained implementation investment with no trial access, while Elicit ($49/mo billed annually) and SciSpace ($12/mo billed annually) serve research use cases at a fraction of the cost.